Conference
IDDF2019-ABS-0136 Sofosbuvir/velpatasvir for 12 weeks is safe and effective in patients undergoing dialysis
Authors
Borgia S; Dearden J; Lurie Y; Shafran S; Brown A; Hyland R; Lu S; Markova S; Dvory-Sobol H; Osinusi A
Pagination
pp. a138.1-a1a138
Publisher
BMJ
Publication Date
June 2019
DOI
10.1136/gutjnl-2019-iddfabstracts.270
Name of conference
Clinical Hepatology